Alcohol Dependence
Conditions
Brief summary
Research has shown that alcohol dependence often co-occurs with comorbid anxiety disorders and/or depression. Anxiety and depression influence the course and treatment of alcohol dependence and are a major risk factor for alcohol relapse within the first three months after detoxification. Therefore, there is need for combined treatment (integrated therapy) of alcohol dependence and comorbid psychiatric disorders, e.g. anxiety and/or depression. Until today, there are no systematic outpatient treatment offers for this special group of patients in Germany. In this study we want to investigate if integrated outpatient cognitive behavioral therapy can prevent and decrease alcohol relapse within the first three months after detoxification. Therefore we hypothesize that immediate start of integrated outpatient psychotherapy will reduce relapse variables compared to treatment as usual which is characterized by non-immediate start of therapy due to the required application for insurance coverage.
Interventions
Integrated CBT intervention for alcohol dependence and comorbid psychiatric disorder (we include only patients with comorbid mood or anxiety disorders).
Sponsors
Study design
Eligibility
Inclusion criteria
* alcohol dependence * comorbid anxiety or mood disorder
Exclusion criteria
* severe mental illness: psychosis, mania, personality disorders * current suicidality * non-compliance with appointments during first 5 sessions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Relapse | 3 months | We assess whether participants have an alcohol relapse (any drinking of alcohol) in the three months after study inclusion |
| Days with heavy alcohol drinking | 3 months | We assess with the Timeline Follow Back (TLFB, Sobell & Sobell, 2000) the number of days with heavy alcohol drinking (for a man 5 or more drinks a day, for a woman 4 or more drinks a day) in the three months after study inclusion |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comorbid psychiatric symptoms | 3 months | Anxiety, depression and other relevant psychiatric symptoms will be measured by different standardized questionnaires at t1 (before treatment) and after 3 months (t2). We will use standardized symptom change as outcome measure. |
Countries
Germany